Atlas Trials

Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma

Clinical trial NCT05833971 · UNKNOWN

Trial details

NCT number
NCT05833971
Sponsor
Guangzhou Institute of Respiratory Disease
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Start date
2023-05-01
Primary completion
2024-06-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.